Silverfin false false 31/03/2025 01/04/2024 31/03/2025 Emma Lorne Graham 27/08/2003 Jonathan Richard Graham 27/08/2003 16 December 2025 The principal activity of the company in the year under review was that of providing physiotherapy, technology and exercise for neurological and musculoskeletal conditions. 04878929 2025-03-31 04878929 bus:Director1 2025-03-31 04878929 bus:Director2 2025-03-31 04878929 2024-03-31 04878929 core:CurrentFinancialInstruments 2025-03-31 04878929 core:CurrentFinancialInstruments 2024-03-31 04878929 core:Non-currentFinancialInstruments 2025-03-31 04878929 core:Non-currentFinancialInstruments 2024-03-31 04878929 core:ShareCapital 2025-03-31 04878929 core:ShareCapital 2024-03-31 04878929 core:RetainedEarningsAccumulatedLosses 2025-03-31 04878929 core:RetainedEarningsAccumulatedLosses 2024-03-31 04878929 core:PlantMachinery 2024-03-31 04878929 core:FurnitureFittings 2024-03-31 04878929 core:PlantMachinery 2025-03-31 04878929 core:FurnitureFittings 2025-03-31 04878929 core:FurtherRelatedPartyRelationshipType2ComponentAllOtherRelatedParties core:CurrentFinancialInstruments 2025-03-31 04878929 core:FurtherRelatedPartyRelationshipType2ComponentAllOtherRelatedParties core:CurrentFinancialInstruments 2024-03-31 04878929 2024-04-01 2025-03-31 04878929 bus:FilletedAccounts 2024-04-01 2025-03-31 04878929 bus:SmallEntities 2024-04-01 2025-03-31 04878929 bus:AuditExemptWithAccountantsReport 2024-04-01 2025-03-31 04878929 bus:PrivateLimitedCompanyLtd 2024-04-01 2025-03-31 04878929 bus:Director1 2024-04-01 2025-03-31 04878929 bus:Director2 2024-04-01 2025-03-31 04878929 core:PlantMachinery core:TopRangeValue 2024-04-01 2025-03-31 04878929 core:FurnitureFittings core:TopRangeValue 2024-04-01 2025-03-31 04878929 2023-04-01 2024-03-31 04878929 core:PlantMachinery 2024-04-01 2025-03-31 04878929 core:FurnitureFittings 2024-04-01 2025-03-31 04878929 core:Non-currentFinancialInstruments 2024-04-01 2025-03-31 iso4217:GBP xbrli:pure

Company No: 04878929 (England and Wales)

PHYSIOFUNCTION LIMITED

UNAUDITED FINANCIAL STATEMENTS
FOR THE FINANCIAL YEAR ENDED 31 MARCH 2025
PAGES FOR FILING WITH THE REGISTRAR

PHYSIOFUNCTION LIMITED

UNAUDITED FINANCIAL STATEMENTS

FOR THE FINANCIAL YEAR ENDED 31 MARCH 2025

Contents

PHYSIOFUNCTION LIMITED

COMPANY INFORMATION

FOR THE FINANCIAL YEAR ENDED 31 MARCH 2025
PHYSIOFUNCTION LIMITED

COMPANY INFORMATION (continued)

FOR THE FINANCIAL YEAR ENDED 31 MARCH 2025
DIRECTORS Emma Lorne Graham
Jonathan Richard Graham
SECRETARY Emma Lorne Graham
REGISTERED OFFICE 1 & 4 Hawthorn Park Holdenby Road
Spratton
Northampton
NN6 8LD
United Kingdom
COMPANY NUMBER 04878929 (England and Wales)
ACCOUNTANT Shaw Gibbs Limited
Eagle House
28 Billing Road
Northampton
NN1 5AJ
PHYSIOFUNCTION LIMITED

BALANCE SHEET

AS AT 31 MARCH 2025
PHYSIOFUNCTION LIMITED

BALANCE SHEET (continued)

AS AT 31 MARCH 2025
Note 2025 2024
£ £
Fixed assets
Tangible assets 4 8,603 14,857
8,603 14,857
Current assets
Stocks 5 1,490 2,641
Debtors 6 63,852 108,778
Cash at bank and in hand 7 90,847 135,933
156,189 247,352
Creditors: amounts falling due within one year 8 ( 104,463) ( 177,626)
Net current assets 51,726 69,726
Total assets less current liabilities 60,329 84,583
Creditors: amounts falling due after more than one year 9 ( 13,108) ( 33,409)
Provision for liabilities ( 2,151) ( 3,714)
Net assets 45,070 47,460
Capital and reserves
Called-up share capital 90 90
Profit and loss account 44,980 47,370
Total shareholders' funds 45,070 47,460

For the financial year ending 31 March 2025 the Company was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies.

Directors' responsibilities:

The financial statements of Physiofunction Limited (registered number: 04878929) were approved and authorised for issue by the Board of Directors on 16 December 2025. They were signed on its behalf by:

Jonathan Richard Graham
Director
PHYSIOFUNCTION LIMITED

NOTES TO THE FINANCIAL STATEMENTS

FOR THE FINANCIAL YEAR ENDED 31 MARCH 2025
PHYSIOFUNCTION LIMITED

NOTES TO THE FINANCIAL STATEMENTS

FOR THE FINANCIAL YEAR ENDED 31 MARCH 2025
1. Accounting policies

The principal accounting policies are summarised below. They have all been applied consistently throughout the financial year and to the preceding financial year, unless otherwise stated.

General information and basis of accounting

Physiofunction Limited (the Company) is a private company, limited by shares, incorporated in the United Kingdom under the Companies Act 2006 and is registered in England and Wales. The address of the Company's registered office is 1 & 4 Hawthorn Park Holdenby Road, Spratton, Northampton, NN6 8LD, United Kingdom.

The financial statements have been prepared under the historical cost convention, modified to include certain items at fair value, and in accordance with Section 1A of Financial Reporting Standard 102 (FRS 102) ‘The Financial Reporting Standard applicable in the UK and Republic of Ireland’ issued by the Financial Reporting Council and the requirements of the Companies Act 2006 as applicable to companies subject to the small companies regime.

The financial statements are presented in pounds sterling which is the functional currency of the Company and rounded to the nearest £.

Going concern

The directors have assessed the Balance Sheet and likely future cash flows at the date of approving these financial statements. The directors have a reasonable expectation that the Company has adequate resources to continue in operational existence and to meet its financial obligations as they fall due for at least 12 months from the date of signing these financial statements. Accordingly, they continue to adopt the going concern basis in preparing the financial statements.

Turnover

Turnover is recognised at the fair value of the consideration received or receivable for goods and services provided in the normal course of business, and is shown net of VAT and other sales related taxes. The fair value of consideration takes into account trade discounts, settlement discounts and volume rebates.

Turnover is recognised when the significant risks and rewards are considered to have been transferred to the customer.

Employee benefits

Defined contribution schemes
The Company operates a defined contribution scheme. The amount charged to the Profit and Loss Account in respect of pension costs and other post-retirement benefits is the contributions payable in the financial year. Differences between contributions payable in the financial year and contributions actually paid are included as either accruals or prepayments in the Balance Sheet.

Taxation

Current tax
Taxation for the year comprises current and deferred tax. Tax is recognised in the Income Statement except to the extent that it relates to items recognised in other comprehensive income or directly in equity.

Current or deferred taxation assets and liabilities are not discounted.

Current tax is recognised at the amount of tax payable using the tax rates and laws that have been enacted or substantively enacted by the balance sheet date.

Deferred tax
Deferred tax is recognised in respect of all timing differences that have originated but not reversed at the balance sheet date.

Timing differences arise from the inclusion of income and expenses in tax assessments in periods different from those in which they are recognised in financial statements. Deferred tax is measured using tax rates and laws that have been enacted or substantively enacted by the year end and that are expected to apply to the reversal of the timing difference.

Unrelieved tax losses and other deferred tax assets are recognised only to the extent that it is probable that they will be recovered against the reversal of deferred tax liabilities or other future taxable profits.

Tangible fixed assets

Tangible fixed assets are stated at cost or valuation, net of depreciation and any provision for impairment. Depreciation is provided on all tangible fixed assets, other than investment property and freehold land, at rates calculated to write off the cost or valuation, less estimated residual value, of each asset on a straight-line or reducing balance basis over its expected useful life, as follows:

Plant and machinery 4 years straight line
Fixtures and fittings 4 years straight line

Depreciation methods, useful lives and residual values are reviewed at each balance sheet date. The selection of these residual values and estimated lives requires the exercise of judgement. The directors are required to assess whether there is an indication of impairment to the carrying value of assets. In making that assessment, judgements are made in estimating value in use. The directors consider that the individual carrying values of assets are supportable by their value in use.

The gain or loss arising on the disposal of an asset is determined as the difference between the sale proceeds and the carrying value of the asset, and is credited or charged to profit or loss.

Leases

The Company as lessee
Assets held under finance leases, hire purchase contracts and other similar arrangements, which confer rights and obligations similar to those attached to owned assets, are capitalised as tangible fixed assets at the fair value of the leased asset (or, if lower, the present value of the minimum lease payments as determined at the inception of the lease) and are depreciated over the shorter of the lease terms and their useful lives. The capital elements of future lease obligations are recorded as liabilities, while the interest elements are charged to the Profit and Loss Account over the period of the leases to produce a constant periodic rate of interest on the remaining balance of the liability.

Rentals under operating leases are charged on a straight-line basis over the lease term, even if the payments are not made on such a basis. Benefits received and receivable as an incentive to sign an operating lease are similarly spread on a straight-line basis over the lease term.

Impairment of assets

Assets, other than those measured at fair value, are assessed for indicators of impairment at each Balance Sheet date. If there is objective evidence of impairment, an impairment loss is recognised in the Profit and Loss Account as described below.

Stocks

Stocks are stated at the lower of cost and estimated selling price less costs to sell, which is equivalent to the net realisable value. Cost includes materials, direct labour and an attributable proportion of manufacturing overheads based on normal levels of activity. Cost is calculated using the FIFO (first-in, first-out) method. Provision is made for obsolete, slow-moving or defective items where appropriate.

At each reporting date, an assessment is made for impairment. Any excess of the carrying amount of stocks over its estimated selling price less costs to complete and sell is recognised as an impairment loss in profit or loss. Reversals of impairment losses are also recognised in profit or loss.

Financial instruments

Cash and cash equivalents in the balance sheet comprise cash at banks and in hand and short term deposits with an original maturity date of three months or less.

Debtors and creditors with no stated interest rate and receivable or payable within one year are recorded at transaction price. Any losses arising from impairment are recognised in the statement of comprehensive income under administrative expenses.

Financial liabilities and equity instruments are classified according to the substance of the contractual arrangements entered into. An equity instrument is any contract that evidences a residual interest in the assets of the entity after deducting all of its financial liabilities.

Where the contractual obligations of financial instruments (including share capital) are equivalent to a similar debt instrument, those financial instruments are classed as financial liabilities. Financial liabilities are presented as such in the balance sheet. Finance costs and gains or losses relating to financial liabilities are included in the profit and loss account. Finance costs are calculated so as to produce a constant rate of return on the outstanding liability.

Where the contractual terms of share capital do not have any terms meeting the definition of a financial liability then this is classed as an equity instrument. Dividends and distributions relating to equity instruments are debited direct to equity.

Provisions

Provisions are recognised when the Company has a present obligation (legal or constructive) as a result of a past event, it is probable that the Company will be required to settle that obligation and a reliable estimate can be made of the amount of the obligation.

The amount recognised as a provision is the best estimate of the consideration required to settle the present obligation at the Balance Sheet date, taking into account the risks and uncertainties surrounding the obligation. Where a provision is measured using the cash flows estimated to settle the present obligation, its carrying amount is the present value of those cash flows (when the effect of the time value of money is material).

2. Critical accounting judgements and key sources of estimation uncertainty

The preparation of financial statements requires the use of certain critical accounting estimates. It also requires management to exercise its judgement in the process of applying the company accounting policies. The areas involving a higher degree of judgement or complexity, or areas where assumptions and estimates are significant to the financial statements are disclosed within the individual accounting policies below.

3. Employees

2025 2024
Number Number
Monthly average number of persons employed by the Company during the year, including directors 16 17

4. Tangible assets

Plant and machinery Fixtures and fittings Total
£ £ £
Cost
At 01 April 2024 142,453 8,098 150,551
Additions 4,601 0 4,601
At 31 March 2025 147,054 8,098 155,152
Accumulated depreciation
At 01 April 2024 129,552 6,142 135,694
Charge for the financial year 9,850 1,005 10,855
At 31 March 2025 139,402 7,147 146,549
Net book value
At 31 March 2025 7,652 951 8,603
At 31 March 2024 12,901 1,956 14,857

5. Stocks

2025 2024
£ £
Stocks 1,490 2,641

6. Debtors

2025 2024
£ £
Trade debtors 59,150 104,750
Amounts owed by connected companies 3,539 1,845
Prepayments 1,163 2,183
63,852 108,778

7. Cash and cash equivalents

2025 2024
£ £
Cash at bank and in hand 90,847 135,933

8. Creditors: amounts falling due within one year

2025 2024
£ £
Bank loans 19,933 16,796
Trade creditors 17,263 21,178
Accruals 3,506 35,624
Corporation tax 23,393 28,049
Other taxation and social security 11,264 22,872
Other creditors 29,104 53,107
104,463 177,626

9. Creditors: amounts falling due after more than one year

2025 2024
£ £
Bank loans 13,108 33,409

There are no amounts included above in respect of which any security has been given by the small entity.